Multidrug-resistant tuberculosis in children: evidence from global surveillance

Matteo Zignol, Charalambos Sismanidis, Dennis Falzon, Philippe Glaziou, Masoud Dara, Katherine Floyd

Source: Eur Respir J 2013; 42: 701-707
Journal Issue: September
Disease area: Paediatric lung diseases, Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Matteo Zignol, Charalambos Sismanidis, Dennis Falzon, Philippe Glaziou, Masoud Dara, Katherine Floyd. Multidrug-resistant tuberculosis in children: evidence from global surveillance. Eur Respir J 2013; 42: 701-707

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Multidrug-resistant tuberculosis in UK children: presentation, management and outcome
Source: Eur Respir J 2013; 41: 1456-1458
Year: 2013


Multidrug-resistant tuberculosis: eight years of surveillance in France
Source: Eur Respir J 2003; 22: 833-837
Year: 2003



Multidrug-resistant tuberculosis and beyond: an updated analysis of the current evidence on bedaquiline
Source: Eur Respir J , 49 (3) 1700146; DOI: 10.1183/13993003.00146-2017
Year: 2017


Multidrug-resistant tuberculosis in a tuberculosis unit – results of five years
Source: Eur Respir J 2006; 28: Suppl. 50, 377s
Year: 2006

Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk
Source: Eur Respir J 2012; 39: 1425-1431
Year: 2012



Multidrug-resistant tuberculosis around the world: what progress has been made?
Source: Eur Respir J 2015; 45: 150-160
Year: 2015



Is multidrug-resistant TB more common in children? An analysis of surveillance data
Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview
Year: 2012

Mycobacterium tuberculosis transmission from patients with drug-resistant compared to drug-susceptible TB: a systematic review and meta-analysis
Source: Eur Respir J, 50 (4) 1701044; 10.1183/13993003.01044-2017
Year: 2017



PG2 Multidrug-resistant tuberculosis management in settings with a low tuberculosis incidence
Source: Milan 2017 - Educational material
Year: 2017

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries
Source: Eur Respir J 2015; 46: 1563-1576
Year: 2015



Management of latent Mycobacterium tuberculosis infection: WHO guidelines for countries with a low tuberculosis burden
Source: International Congress 2016 – ERS publications: a focus on recent guidelines and task forces
Year: 2016


Multidrug-resistant tuberculosis in children of Belarus
Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis
Year: 2021


Multidrug-resistant tuberculosis
Source: Annual Congress 2008 - The thoracic surgeon facing infection
Year: 2008


Management of multidrug-resistant tuberculosis and patients in retreatment
Source: Eur Respir J 2005; 25: 928-936
Year: 2005



Multidrug-resistant TB in children with HIV infection
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007


HIV and multidrug-resistant tuberculosis: overlapping epidemics
Source: Eur Respir J 2014; 44: 251-254
Year: 2014


Comorbidome in multidrug-resistant tuberculosis patients
Source: Virtual Congress 2020 – Tuberculosis and comorbidities
Year: 2020


Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in a metropolitan city
Source: Eur Respir J 2013; 41: 901-908
Year: 2013



Multidrug-resistant tuberculosis (MDR-TB)
Source: Breathe 2010; 6: 283
Year: 2010

Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence
Source: Eur Respir J 2016; 47: 394-402
Year: 2016